Kristina Hicks Shea, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 36321 State Highway 79 Ste 2, Cleveland, AL 35049 Phone: 205-274-8000 Fax: 205-274-8019 |
Kim Larue, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 36321 State Highway 79 Ste 2, Cleveland, AL 35049 Phone: 205-274-8000 Fax: 205-274-8019 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
Treatment with the targeted drug rituximab can significantly benefit some patients with severe lupus nephritis who do not respond to conventional therapy, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Among patients at risk of heart failure, collaborative care based on screening for certain levels of brain-type natriuretic peptide reduced the combined rates of left ventricular systolic dysfunction, diastolic dysfunction, and heart failure as well as emergency cardiovascular hospitalizations, according to a study in the July 3 issue of JAMA.
A neuroscience study provides new insight into the primal brain circuits involved in collision avoidance, and perhaps a more general model of how neurons can participate in networks to process information and act on it.
› Verified 4 days ago